BRIANA HUYCK: Open Payments
NPI 1720594914 · IRMO, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 46 payments from 12 companies in 2025. Trend: 2023 $592 · 2024 $1,096 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $175 |
| ABBVIE INC. | 14 | $160 |
| Abbott Laboratories | 3 | $60 |
| PFIZER INC. | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Novo Nordisk Inc | 2 | $42 |
| Corcept Therapeutics | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Stryker Corporation | 1 | $22 |
Products named: OTEZLA, VRAYLAR, XIFAXAN, KRYSTEXXA, UBRELVY, Korlym, VOQUEZNA, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
